Colorado statutory context
A statute-focused read of Colorado’s limits on ibogaine: what Proposition 122 changed, what it did not change, and why federal law remains material.
The short answer
Colorado’s Natural Medicine Health Act, adopted through Proposition 122 and now codified principally at Colo. Const. art. XVIII, § 16, includes ibogaine within “natural medicine.” For adults age 21 or older, the measure removed certain state-law criminal penalties for personal use, possession, cultivation, and sharing without remuneration in the measure’s stated circumstances.
That is not the same as a general retail market, unrestricted sale, federally approved treatment, or immunity from all state and federal consequences. This page follows the statutory boundary first; for broader orientation on the subject, the Colorado ibogaine context offers a starting point, while the site’s source and independence principles explain how this resource approaches uncertainty.
Federal law remains central. Ibogaine is listed as a Schedule I controlled substance in federal regulation, 21 C.F.R. § 1308.11. State decriminalization does not amend that federal classification or prevent federal authorities from enforcing federal law.
Three statutory distinctions
Article XVIII, § 16 identifies a narrow state-law protection for specified adult conduct involving natural medicine. It is conduct-specific and age-specific; it is not a blanket declaration that every transaction or setting is lawful.
The constitutional framework separately authorizes a regulated natural medicine services program. That framework is not a general authorization for any person to sell, administer, or market ibogaine outside its rules.
The state rule does not erase the federal Schedule I classification. DEA scheduling information describes the federal schedules and the separate federal framework that can still apply.
Primary text first
The operative constitutional language places ibogaine among the substances defined as natural medicine. It states that possession, storage, consumption, cultivation, and certain sharing without remuneration by people 21 or older are not offenses under Colorado law, subject to the measure’s definitions and limitations.
A practical reading should keep the words “without remuneration” in view. A payment, commercial arrangement, public offering, or conduct beyond the text may present a different legal question. The difference between decriminalization and a commercial authorization is not merely semantic.
Colorado Constitution, Article XVIII, § 16: “Natural Medicine.” Consult the enacted ballot measure text alongside current Colorado statutes and rules.
2026 research question
The referenced 2026 bill is distinct from Proposition 122’s constitutional framework. Its scope, eligibility, licensing caps, permitted activities, enactment status, and any implementing rules should be confirmed against the current official bill record rather than inferred from a proposal title.
For a bill labeled HB 26-1325, determine whether it passed, was amended, or was enacted, then read the final session-law language. A bill summary may not capture operative restrictions, definitions, or effective dates.
A state research pilot can define a limited program without turning ibogaine into an FDA-approved drug or creating general permission for medical practice. The FDA drug development and approval process is a separate federal pathway.
Where a program uses eligibility rules, license caps, site requirements, recordkeeping, or limits on acquisition and administration, those details determine who may participate and what activity is permitted. They cannot safely be generalized beyond the operative text.
A Colorado authorization does not itself create a federal exemption. Research involving a Schedule I substance may implicate federal registration and related requirements; uncertainty should be resolved by counsel and the controlling primary materials.
Conduct matters
These are general distinctions drawn from the state and federal framework, not individualized legal advice. The facts, location, age, role, transaction, and current law can alter the analysis.
Questions of scope
Legal status is not a clinical recommendation. For information that focuses on practical limits and uncertainty, see the site’s access and risk discussion.
No. It creates defined state-law protections for certain adult conduct involving natural medicine. It does not establish general commercial legality, federal legality, or approved medical treatment. For a wider federal-state comparison, the question of ibogaine’s legality in the United States is useful context.
No. Colorado cannot reclassify a substance under federal law. Ibogaine’s Schedule I status remains relevant to federal enforcement and to conduct involving interstate travel, importation, or federally regulated research. The long-term dimension is discussed separately in ibogaine’s long-term side-effects context, which does not change the legal analysis.
No. The actual program text controls. A pilot can be limited by eligibility, licensure, participant criteria, site conditions, and permitted activity. It should be read separately from accounts of ibogaine treatment centers in Canada, which concern another jurisdiction and do not establish Colorado legal status.
Read the controlling constitutional and statutory text, current agency materials, and any final rule or bill history. For questions with personal legal consequences, consult qualified counsel. Topic-specific narratives about ibogaine and military communities, ibogaine and ALS, or ibogaine and brain de-aging cannot substitute for the operative Colorado and federal texts.
A careful next step
Colorado law is evolving, and the answer can turn on conduct and timing. This primer is a general explanatory resource, not medical or legal advice; consult the primary text and qualified counsel for a fact-specific question.